Skip to main content

Industry News

Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.

University of Cambridge Opens Ray Dolby Centre

Published 6/3/2025

The University of Cambridge opened the Ray Dolby Centre in May of 2025 in the United Kingdom. This purpose-built headquarters for the Department of Physics, also known as the Cavendish Laboratory, will serve as a national research hub and houses the Collaborative R&D Environment (CORDE), a new facility for the Engineering and Physical Sciences Research Council.

Read More

RWJBarnabas Health and Rutgers Celebrate Morris Cancer Center Opening

Published 5/30/2025

RWJBarnabas Health and Rutgers Cancer Institute of New Jersey opened the $1 billion Jack & Sheryl Morris Cancer Center in May of 2025 in New Brunswick. Designed by HOK, the 520,000-sf building collocates world-class research environments with welcoming settings for clinical care to optimize patient outcomes.

Read More

Old Dominion University Breaks Ground on Biological Sciences Building

Published 5/29/2025

Old Dominion University broke ground in April of 2025 on the Biological Sciences Building in Norfolk, Va. Representing the largest capital construction project in the institution's history, the $184 million development will enable students and faculty to explore a wide range of biomedical and ecological fields. Ballinger and VMDO Architects designed the 162,586-sf structure, which will provide flexible research labs for up to 30 investigators, teaching labs, core facilities, classrooms, and a 120-seat lecture hall.

Read More

AstraZeneca Opens Rockville Cell Therapy Facility

Published 5/27/2025

AstraZeneca opened a $300 million cell therapy facility in May of 2025 in Rockville, Md. Developed by Alexandria Real Estate Equites, the 84,264-rsf building features specialized environments for the production of chimeric antigen receptor therapies (CAR-T) and T-cell receptor therapies (TCR-T). Next-generation biomanufacturing suites will leverage advanced process controls to create life-saving personalized medicine treatments, spanning every step from culturing and formulation to testing.

Read More